Do-Coop Drug Delivery Systems, Drug Development for the Pharma Industry

January 15th, 2008: New publication release - Enhancment of Hybridoma formation, clonability and cell proliferation utilizing Neowater® Technology

   
Do-Coop Technologies Ltd. is proud to announce the release of a new scientific paper titled "Enhancement of hybridoma formation, clonability and cell proliferation in a nanoparticle-doped aqueous environment" by Natalie Gavrilov-Yusim1, Ekaterina Hahiashvili1, Marina Tashker1, Victoria Yavelsky1, Ohad Karnieli2 and Leslie Lobel1*

1Department  of Virology  and Developmental Genetics,  Ben Gurion University  of  the Negev,
Beersheva 84105, Israel
 
2Department of Human Molecular Genetics and Biochemistry, Sackler School of Medicine, Tel
Aviv University, Tel Aviv 69978, Israel
 
* Corresponding author:
Leslie Lobel
Department of Virology and Developmental Genetics
Ben Gurion University of the Negev
Beersheva 84105, Israel
E-mail: llobel@bgu.ac.il
Phone:  +972-8-6479941 
Mobile:  +972-54-2156235 

 
   
For several years, Dr. lobel's group members have tested and evaluated the effects of Neowater® (Nanoparticle-doped water or NPD water) on various aspects of Hybridoma formation, antibody secretion and cell proliferation and have successfully published their results in the journal of Biomed Central Biotechnology (BMC Botechnology). You are encouraged to click here and download the pre-released paper draft.
 

Drug development | Enzyme Stabilization | Protein Stabilization | PharmaPharmaceutical companies